Withholding research results in academic life science. Evidence from a national survey of faculty

D. Blumenthal, E. G. Campbell, M. S. Anderson, N. Causino and K. S. Louis
Health Policy Research and Development Unit, Boston, MA 02114, USA.

OBJECTIVES: To identify the prevalence and determinants of data-withholding behaviors among academic life scientists. DESIGN: Mailed survey of 3394 life science faculty in the 50 universities that received the most funding from the National Institutes of Health in 1993. PARTICIPANTS: A total of 2167 faculty responded to the survey, a 64% response rate. OUTCOME MEASURES: Whether respondents delayed publication of their research results for more than 6 months and whether respondents refused to share research results with other university scientists in the last 3 years. RESULTS: A total of 410 respondents (19.8%) reported that publication of their research results had been delayed by more than 6 months at least once in the last 3 years to allow for patent application, to protect their scientific lead, to slow the dissemination of undesired results, to allow time to negotiate a patent, or to resolve disputes over the ownership of intellectual property. Also, 181 respondents (8.9%) reported refusing to share research results with other university scientists in the last 3 years. In multivariate analysis, participation in an academic-industry research relationship and engagement in the commercialization of university research were significantly associated with delays in publication. Odds ratios (ORs) and 95% confidence intervals (CIs) were 1.34 (1.07-1.59) and 3.15 (2.88-3.41), respectively. Variables associated with refusing to share results were conducting research similar to the Human Genome Project (OR, 2.09; 95% CI, 1.75-2.42), publication rate (OR, 1.02; 95% CI, 1.01-1.03), and engagement in commercialization of research (OR, 2.45; 95% CI, 2.08-2.82). CONCLUSIONS: Withholding of research results is not a widespread phenomenon among life-science researchers. However, withholding is more common among the most productive and entrepreneurial faculty. These results also suggest that data withholding has affected a significant number of life-science faculty and further study on data-withholding practices is suggested.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Commercially Funded and United States-Based Research Is More Likely to Be Published; Good-Quality Studies with Negative Outcomes Are Not
Lynch et al.
JBJS 2007;89:1010-1018.
ABSTRACT | FULL TEXT  

Conflicts of interest in biomedical research-- the FASEB guidelines
Brockway and Furcht
FASEB J. 2006;20:2435-2438.
ABSTRACT | FULL TEXT  

Medical-Process Patents -- Monopolizing the Delivery of Health Care
Kesselheim and Mello
NEJM 2006;355:2036-2041.
FULL TEXT  

Conflict of interest in psychiatry
Ahmer et al.
Psychiatr. Bull. 2005;29:302-304.
ABSTRACT | FULL TEXT  

Knowledge commons or economic engine - what's a university for?
Williams-Jones
J. Med. Ethics 2005;31:249-250.
FULL TEXT  

Identifying outcome reporting bias in randomised trials on PubMed: review of publications and survey of authors
Chan and Altman
BMJ 2005;330:753.
ABSTRACT | FULL TEXT  

University-Based Science and Biotechnology Products: Defining the Boundaries of Intellectual Property
Kesselheim and Avorn
JAMA 2005;293:850-854.
ABSTRACT | FULL TEXT  

Implications of Pharmaceutical Industry Funding on Clinical Research
Lexchin
The Annals of Pharmacotherapy 2005;39:194-197.
ABSTRACT | FULL TEXT  

Randomized clinical trials: What gets published, and when?
Hirsch
CMAJ 2004;170:481-483.
FULL TEXT  

Institutional ethics review of clinical study agreements
DuVal
J. Med. Ethics 2004;30:30-34.
ABSTRACT | FULL TEXT  

Conflicts of Interest and AJRCCM: Restating Policy and a New Form to Upload
Tobin
Am. J. Respir. Crit. Care Med. 2003;167:1161-1164.
FULL TEXT  

Watching the Race to Find the Breast Cancer Genes
Dalpe et al.
Science Technology Human Values 2003;28:187-216.
ABSTRACT  

Scope and Impact of Financial Conflicts of Interest in Biomedical Research: A Systematic Review
Bekelman et al.
JAMA 2003;289:454-465.
ABSTRACT | FULL TEXT  

Judging the judges: the role of journal editors
Ray
QJM 2002;95:769-774.
FULL TEXT  

A National Survey of Provisions in Clinical-Trial Agreements between Medical Schools and Industry Sponsors
Schulman et al.
NEJM 2002;347:1335-1341.
ABSTRACT | FULL TEXT  

Financial Conflicts of Interest in Human Subjects Research: The Problem of Institutional Conflicts
Barnes and Florencio
J Law Med Ethics 2002;30:390-402.
 

Patenting of genetic material: Are the benefits to society being realized?
Willison and MacLeod
CMAJ 2002;167:259-262.
FULL TEXT  

Scientific Data from Clinical Trials: Investigators' Responsibilities and Rights
Ann. Surg. Oncol. 2002;9:421-422.
FULL TEXT  

Scientific Data From Clinical Trials: Investigators' Responsibilities and Rights
Arch Surg 2002;137:639-640.
FULL TEXT  

Responsibilities of investigators
Sade and McKneally
J. Thorac. Cardiovasc. Surg. 2002;123:837-838.
FULL TEXT  

Responsibilities of investigators
Sade and McKneally
Ann. Thorac. Surg. 2002;73:1364-1365.
FULL TEXT  

From Clinical Trial to Prescription
Carpenter
Arch Gen Psychiatry 2002;59:282-285.
ABSTRACT | FULL TEXT  

Data Withholding in Academic Genetics: Evidence From a National Survey
Campbell et al.
JAMA 2002;287:473-480.
ABSTRACT | FULL TEXT  

Attacks on Science: The Risks to Evidence-Based Policy
Rosenstock and Lee
Am. J. Public Health 2002;92:14-18.
ABSTRACT | FULL TEXT  

Sponsorship, Authorship, and Accountability
Davidoff et al.
Obstet Gynecol 2001;98:1143-1146.
FULL TEXT  

Sponsorship, Authorship, and Accountability
Davidoff et al.
Arch Otolaryngol Head Neck Surg 2001;127:1178-1180.
FULL TEXT  

Sponsorship, Authorship, and Accountability
Davidoff et al.
ANN INTERN MED 2001;135:463-466.
FULL TEXT  

Maintaining the integrity of the scientific record
Smith
BMJ 2001;323:588-588.
FULL TEXT  

Sponsorship, Authorship, and Accountability
Davidoff et al.
JAMA 2001;286:1232-1234.
FULL TEXT  

Sponsorship, authorship and accountability
Davidoff et al.
CMAJ 2001;165:786-788.
FULL TEXT  

Outcomes of a Trial of HIV-1 Immunogen in Patients With HIV Infection
Dat et al.
JAMA 2001;285:2191-2195.
FULL TEXT  

Technology Transfer: A Review for Biomedical Researchers
Kneller
Clin. Cancer Res. 2001;7:761-774.
ABSTRACT | FULL TEXT  

Evaluation of HIV-1 Immunogen, an Immunologic Modifier, Administered to Patients Infected With HIV Having 300 to 549 x 106/L CD4 Cell Counts: A Randomized Controlled Trial
Kahn et al.
JAMA 2000;284:2193-2202.
ABSTRACT | FULL TEXT  

Policies on Faculty Conflicts of Interest at US Universities
Cho et al.
JAMA 2000;284:2203-2208.
ABSTRACT | FULL TEXT  

Assessing Faculty Financial Relationships With Industry: A Case Study
Boyd and Bero
JAMA 2000;284:2209-2214.
ABSTRACT | FULL TEXT  

Conflict of Interest and the Public Trust
DeAngelis
JAMA 2000;284:2237-2238.
FULL TEXT  

Uneasy Alliance -- Clinical Investigators and the Pharmaceutical Industry
Bodenheimer
NEJM 2000;342:1539-1544.
FULL TEXT  

The Plight of Academic Health Centers
DeAngelis
JAMA 2000;283:2438-2439.
FULL TEXT  

Market Forces and Unsponsored Research in Academic Health Centers
Weissman et al.
JAMA 1999;281:1093-1098.
ABSTRACT | FULL TEXT  

Looking a Gift Horse in the Mouth: Corporate Gifts Supporting Life Sciences Research
Campbell et al.
JAMA 1998;279:995-999.
ABSTRACT | FULL TEXT  

Effect of the Statistical Significance of Results on the Time to Completion and Publication of Randomized Efficacy Trials
Ioannidis
JAMA 1998;279:281-286.
ABSTRACT | FULL TEXT  

Vulnerability and Disclosure in Science: The Interplay Between Agency and Structure
GOLDBERG
Science Communication 1997;19:99-123.
ABSTRACT  

Suppressed Study Released: Brand and Generic Levothyroxine Bioequivalent
JWatch Psychiatry 1997;1997:18-18.
FULL TEXT  

SUPPRESSED STUDY RELEASED: BRAND AND GENERIC LEVOTHYROXINE FOUND BIOEQUIVALENT
JWatch General 1997;1997:1-1.
FULL TEXT  

Sponsorship, Authorship, and Accountability
Davidoff et al.
NEJM 2001;345:825-827.
FULL TEXT